HKD8.17
5.83% day before yesterday
Hong Kong, Aug 22, 10:08 am CET
ISIN
KYG8167W1380
Symbol
1177

Sino Biopharmaceutical Stock price

HKD8.17
+1.27 18.41% 1M
+4.74 138.19% 6M
+4.97 155.31% YTD
+4.96 154.52% 1Y
+3.99 95.45% 3Y
-1.22 12.99% 5Y
+5.89 257.64% 10Y
+7.94 3,386.98% 20Y
Hong Kong, Closing price Fri, Aug 22 2025
+0.45 5.83%
ISIN
KYG8167W1380
Symbol
1177
Industry

Key metrics

Basic
Market capitalization
HKD138.1b
Enterprise Value
HKD129.5b
Net debt
positive
Cash
HKD21.6b
Shares outstanding
17.9b
Valuation (TTM | estimate)
P/E
34.0 | 44.0
P/S
4.1 | 3.8
EV/Sales
3.9 | 3.6
EV/FCF
-
P/B
3.8
Dividends
DPS
HKD0.09
Yield 1Y | 5Y
1.1% | 1.5%
Growth 1Y | 5Y
50.0% | 6.2%
Payout 1Y | 3Y
42.9% | 47.9%
Increased
1 Year
Financials (TTM | estimate)
Revenue
HKD33.3b | HKD35.9b
EBITDA
- | HKD9.1b
EBIT
HKD7.6b | HKD7.6b
Net Income
HKD4.2b | HKD3.3b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
14.1% | 14.1%
EBITDA
- | 13.0%
EBIT
12.9% | 14.7%
Net Income
-5.4% | -12.9%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
81.8%
EBITDA
- | 25.3%
EBIT
22.9%
Net
12.7% | 9.3%
Free Cash Flow
-
Financial Health
Equity Ratio
48.9%
Return on Equity
11.0%
ROCE
14.0%
ROIC
15.9%
Debt/Equity
0.4
More
EPS
HKD0.2
FCF per Share
-
Short interest
-
Employees
24k
Rev per Employee
HKD1.3m
Show more

Is Sino Biopharmaceutical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Sino Biopharmaceutical Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Sino Biopharmaceutical forecast:

26x Buy
93%
2x Hold
7%

Analyst Opinions

28 Analysts have issued a Sino Biopharmaceutical forecast:

Buy
93%
Hold
7%

Financial data from Sino Biopharmaceutical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
33,337 33,337
14% 14%
100%
- Direct Costs 6,078 6,078
22% 22%
18%
27,259 27,259
12% 12%
82%
- Selling and Administrative Expenses 14,020 14,020
12% 12%
42%
- Research and Development Expense 6,215 6,215
23% 23%
19%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 7,617 7,617
13% 13%
23%
Net Profit 4,222 4,222
5% 5%
13%

In millions HKD.

Don't miss a Thing! We will send you all news about Sino Biopharmaceutical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.

Head office Cayman Islands
CEO S Tse
Employees 24,379
Founded 2000
Website www.sinobiopharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today